Herd immunity counter to COVID-19 should be achieved by protecting people through vaccination, not exposing them to the pathogen that causes the disease. To safely attain herd immunity against COVID-19, a considerable proportion of a global people would need to be immunized or vaccinated, lowering the overall amount of virus to spread in the whole global communities and societies. The herd immunity concept intends to keep vulnerable groups who cannot get vaccinated (for instance, health conditions such as allergic reactions to the vaccine) safe and protected from the COVID-19 virus.

1. PHARMACEUTICAL INDUSTRY: KEEPING WORLD HEALTHY IN PANDEMIC
Healthcare & Life
Sciences

2. The novel COVID-19 (coronavirus disease 2019)
was categorized as a global pandemic by the
World Health Organization (WHO) on 11th
March 2020. This COVID-19 pandemic had
significant effects on the pharmaceutical
market, the health sector and was associated
with considerable impacts, which may appear
in the short-term and long-term that primarily
need identification and appropriate planning to
reduce their socio-economic burden.
Pharmaceutical Sector: COVID-19 Short and
Long-Term Impacts
COVID-19 revealed the pharmaceutical
industry's most significant opportunity, which is
the growing demand for prescription
medicines, medical devices, and vaccines in the
global market. This expected to be one of the
leading short-term effects of the COVID-19
pandemic; however, there are more short-term
and long-term implications to it
Pukka partners

3. Short-Term COVID-19 Impacts on the Pharmaceutical Industry
Demand change, panic buying and stocking, supply shortages, regulation changes, shift of promotions and
communication through remote interactions technologies or platforms such as Zoom, WhatsApp, and Skype.
Such practice of process can be seen as short-term impacts of the COVID-19 on the pharma market.

4. Long-Term COVID-19 Impacts on the
Pharmaceutical Industry
Approval delays, moving towards self-
sufficiency in the pharmaceutical
manufacturing supply chain, slow industry
growth, and possible consumption trend
variations could be seen as the long-term
impact of the COVID-19 on the health and
pharmaceutical market.
Pharma Market Insights – Size and Dynamics by Geography

5. Pukka partners
1 Germany, France, Spain, Italy, UK – 2 Ex-factory price before rebates – 3 Russia, Brazil, India – 4 US & Canada
 The global pharmaceutical market is expected to grow with a CAGR of +4.4% by 2024, including the impact of COVID-19,
which would negatively impact volumes for 4 to 6 months in 2020 and create higher pricing pressure on the global market
in the next five years
 North America should continue to dominate with a 43% value share of the global pharma market in 2019 and contribute
to 44% to worldwide market growth during the 2019–2024 period
Keeping World Healthy in Pandemic: Herd Immunity Trend
Herd immunity counter to COVID-19 should be achieved by protecting people through vaccination, not exposing them to the
pathogen that causes the disease. To safely attain herd immunity against COVID-19, a considerable proportion of a global
people would need to be immunized or vaccinated, lowering the overall amount of virus to spread in the whole global
communities and societies. The herd immunity concept intends to keep vulnerable groups who cannot get vaccinated (for
instance, health conditions such as allergic reactions to the vaccine) safe and protected from the COVID-19 virus.
The acceptable percentage of people for the vaccination process can be varied with the quality and impact of each disease in
the end market. For instance, herd immunity against measles requires around 95% of the total population to be vaccinated. The
remaining 5% will be protected owing to measles will not spread among the vaccinated population. For polio, the threshold is
almost 80%. Therefore, the proper proportion of the people that needs to be immunized against the COVID-19 virus to begin
bringing herd immunity is unknown or uncalculated.

6. Impact Middle-East EU5 countries United States
+10.8%: OTC category (cold, cough)
COVID-19 related +403%: Personal hygiene +62%: Personal hygiene
Medicines used in hospitals for the treatment of COVID-19 have increased between
100% and 700% since the beginning of January
+67%: ICU medications
+23%: Lipid-lowering
Medication shortage due to
induced demand
General (panic buying) +40%: Anti-diabetes
+29.1%: Anti-hypertensives
Short-term Impact Supply shortage
Drugs for chronic diseases are at high risk of shortage
or faced supply chain disruption
The supply shortage of both finished products and active APIs (It is estimated that
around 40% of generic drug APIs for the US market are procured from the Indian
Market)
The supply shortage of COVID-19 related complications treatment
R & D shifts 156 clinical trials are running for COVID-19 140 clinical trials are running for COVID-19
Shifts towards telemedicine
WhatsApp calls are the most favored digital
channel for both communication with peers and
patient consultation
In Spain, a 320% increase (v. PY) in remote
interactions. The corresponding rise in Italy (v. PY)
was 471%
70–80% reduction in the number of patient visits to doctor offices
Digital channel has wide adoption with over 75%
of physicians, but physicians prefer traditional F2F
communication
51% decline in specialist consultations and a 25%
decline in GPs visits
Tele-medicine growth accounts for 23% of interactions
Long-term Impact
16% delay new trials only 32% delay new trials
and existing patient enrolment
Product launches delayed, disrupted, or impacted
Shifts towards self-sufficiency in the
pharmaceutical sector
Free movement of capital and direct investment from
other countries

7. Recent News of Pharmaceutical Industry Trends:
•On 18th May 2020, Johnson & Johnson announced collaboration between the Janssen Pharmaceutical Companies of
Johnson & Johnson and BioSolutions, Inc. to upkeep its COVID-19 vaccine candidate's manufacturing facilities.
•On 24th February 2020, Sanofi planned to form a leading European company that will drive the production and marketing
to third parties of active pharmaceutical ingredients (API). These are the essential molecules used in the composition and
production of any drug.
Pharmaceutical Industry Trends 2020 Benefits:
•Pharmaceutical Industry Trends give per perspective of Customer Expectations which Are Rising Continuously.
•The growing importance of emerging markets can be understood by the study of pharmaceutical industry trends.
•If you are not tracking enough data, you won't see how Pharmaceutical Industry Trends change over time or why some
users behave one way versus another
Conclusion
The COVID-19 global pandemic can be accompanying numerous short-term and long-term COVID-19 pandemic impacts on
the pharmaceutical market, which can be seen from international and domestic perspectives. Identifying these impacts may
guide policy-makers in evidence-informed planning and decision-making to combat associated challenges with the outbreak
of the COVID-19 pandemic. For proper planning to prevent long-term difficulties, short-term results should be measured
and determined with appropriate data analysis methods. Identification of these effects is vital for policy-makers and
decision-makers to guide more evidence-informed planning to overcome associated challenges and difficulties. This is
estimated to be more critical in developing countries with more scarce healthcare resources and pharma emerging markets.
Full me Engagement

8. How We Are :-
Pukka Partners provide customized intelligence solutions to C-suite
executives and functional growth leaders, along with other key
offerings including market & competitive intelligence, management
& strategy consulting, pre-investment advisory, real-time business
intelligence, and data analytics services across sectors, globally and
locally, on new & emerging markets and disruptive technologies.
We offer advisory and actionable insights around public policies,
investment tracking along with the obstacles faced by investors,
innovation and strategy impact monitoring, identification of
industry potential, and technology mapping through
comprehensive and standardized research methodology and tools.
We deploy our solutions to solve prioritized and critical business
challenges by leveraging our in-house expertise and continuous
engagement with industry thought leaders in the business
ecosystem.
Contact Us:- engage@pukkapartners.com
Website:- https://www.pukkapartners.com